HSF1 and neoplasm: Stimulating mTORC1 in these <i>HSF1</i>-deficient cells drives catastrophic proteomic imbalance, triggering pronounced cell death, in part through unchecked amyloidogenesis, and suppressing tumor growth <i>in vivo</i>.